TREATMENT OF KNEE OSTEOARTHRITIS WITH SM04690 IMPROVED WOMAC A1 'PAIN ON WALKING' RESULTS FROM A 52 WEEK, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2 STUDY OF A NOVEL, INTRA-ARTICULAR, WNT PATHWAY INHIBITOR

被引：5
|
作者：
Kennedy, S. [1 ]
Ghandehari, H. [1 ]
Swearingen, C. [1 ]
Tambiah, J. [1 ]
Hochberg, M. [2 ]
机构：
[1] Samumed LLC, San Diego, CA USA
[2] Univ Maryland, Sch Med, Baltimore, MD 21201 USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2018年 / 77卷
关键词：
D O I：
10.1136/annrheumdis-2018-eular.5547
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
OP0061
引用
收藏
页码：81 / 82
页数：2
相关论文
共 50 条
  • [41] Radiographic Outcomes Were Associated with Pain and Function Responses: Post-Hoc Analysis of Results from a Phase 2 Study of a Small Molecule Wnt Pathway Inhibitor, SM04690, for Knee Osteoarthritis Treatment
    Yazici, Yusuf
    McAlindon, Timothy E.
    Gibofsky, Allan
    Lane, Nancy E.
    Skrepnik, Nebojsa
    Armas, Eddie
    Swearingen, Christopher J.
    DiFrancesco, Anita
    Tambiah, Jeymi
    Hochberg, Marc
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [42] A first-in-human, double-blind, randomised, placebo-controlled, dose ascending study of intra-articular rhFGF18 (sprifermin) in patients with advanced knee osteoarthritis
    Dahlberg, L. E.
    Aydemir, A.
    Muurahainen, N.
    Guehring, H.
    Edebo, H. Fredberg
    Krarup-Jensen, N.
    Ladel, C. H.
    Jurvelin, J. S.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (03) : 443 - 450
  • [43] Intra-articular Canakinumab (anti-interleukin-1β) for Treatment of Symptomatic Knee Osteoarthritis: A Randomized, Double-blind, Placebo and Naproxen-controlled Phase II Study
    Conaghan, Philip
    Chevalier, Xavier
    Mindeholm, Linda
    Schramm, Ursula
    Praestgaard, Jens
    Seroutou, Abdelkader
    Roubenoff, Ronenn
    Schieker, Matthias
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 1474 - 1475
  • [44] EFFICACY AND SAFETY OF AN INTRA-ARTICULAR INJECTION OF JTA-004, A NOVEL ENHANCED PROTEIN SOLUTION, IN KNEE OSTEOARTHRITIS PAIN: A RANDOMISED, DOUBLE-BLIND CONTROLLED PHASE II/III STUDY
    Bettonville, M.
    Leon, M.
    Margaux, J.
    Urbin-Choffray, D.
    Theunissen, E.
    Besse-Hammer, T.
    Fortems, Y.
    Verlinden, S.
    Godeaux, O.
    Delmarcelle, A. -S.
    Kaux, J. -F.
    OSTEOPOROSIS INTERNATIONAL, 2020, 31 (SUPPL 1) : S46 - S46
  • [45] EFFICACY AND SAFETY OF AN INTRA-ARTICULAR INJECTION OF JTA-004, A NOVEL ENHANCED PROTEIN SOLUTION, IN KNEE OSTEOARTHRITIS PAIN: A RANDOMISED, DOUBLE-BLIND CONTROLLED PHASE II/III STUDY
    Bettonville, M.
    Leon, M.
    Margaux, J.
    Urbin-Choffray, D.
    Theunissen, E.
    Besse-Hammer, T.
    Fortems, Y.
    Verlinden, S.
    Godeaux, O.
    Delmarcelle, A. S.
    Kaux, J. F.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 794 - 794
  • [46] PRELIMINARY RESULTS FROM A PHASE 1B DOUBLE-BLIND STUDY TO ASSESS THE SAFETY, TOLERABILITY AND EFFICACY OF INTRA-ARTICULAR ADMINISTRATION OF RESINIFERATOXIN OR PLACEBO FOR THE TREATMENT OF MODERATE TO SEVERE PAIN DUE TO OSTEOARTHRITIS OF THE KNEE
    Leiman, D.
    Minkowitz, H.
    Levitt, R. C.
    Solanki, D.
    Horn, D.
    Janfaza, D.
    Sarno, D.
    Albores-Ibarra, N.
    Bai, X.
    Takeshita, K.
    Zhao, T.
    Lu, C. -W.
    Bharathi, P.
    Ahern, J.
    Klincewicz, S.
    Nedeljkovic, S. S.
    OSTEOARTHRITIS AND CARTILAGE, 2020, 28 : S138 - S138
  • [47] Elagolix Treatment for Endometriosis-Associated Pain: Results from a Phase 2, Randomized, Double-Blind, Placebo-Controlled Study
    Diamond, Michael P.
    Carr, Bruce
    Dmowski, W. Paul
    Koltun, William
    O'Brien, Chris
    Jiang, Ping
    Burke, Joshua
    Jimenez, Roland
    Garner, Elizabeth
    Chwalisz, Kristof
    REPRODUCTIVE SCIENCES, 2014, 21 (03) : 363 - 371
  • [48] Elagolix Treatment for Endometriosis-Associated Pain: Results from a Phase 2, Randomized, Double-Blind, Placebo-Controlled Study
    Michael P. Diamond
    Bruce Carr
    W. Paul Dmowski
    William Koltun
    Chris O’Brien
    Ping Jiang
    Joshua Burke
    Roland Jimenez
    Elizabeth Garner
    Kristof Chwalisz
    Reproductive Sciences, 2014, 21 : 363 - 371
  • [49] A Randomized, Double-blind, Placebo-controlled, Single Injection, 52-Week Study to Evaluate the Efficacy and Safety of an Intra-articular Injection (IAI) of CNTX-4975-05 (CNTX) in Subjects with Chronic, Moderate-to-severe Osteoarthritis Knee Pain (OAKP) - Study 301
    Stevens, Randall
    Campbell, James N.
    Newman, Colleen
    Connolly, James
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 632 - 634
  • [50] A Randomized, Double-blind, Placebo-controlled, Repeat Injection, 52-Week Study to Evaluate the Efficacy and Safety of an Intra-articular Injection (IAI) of CNTX-4975-05 (CNTX) in Subjects with Chronic, Moderate-to-severe Osteoarthritis Knee Pain (MSOAKP) - Study 304
    Connolly, James
    Campbell, James N.
    Stevens, Randall
    Newman, Colleen
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 630 - 632
12345